Autres langues Photocure ASA

Actions

PHO

NO0010000045

Produits pharmaceutiques

Marché Fermé - Oslo Bors 16:45:00 19/08/2026			Varia. 5j.	Varia. 1 janv.
54,00 ^NOK	-2,88%		+2,47%	-24,37%

16/08	Photocure entrevoit un fort potentiel dans le projet de reclassification des systèmes de cystoscopie par la FDA	MT
14/08	Photocure ASA : la FDA propose de reclasser les systèmes de cystoscopie en lumière bleue de la classe III à la classe II	CI

Autres langues

17/08	Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II
16/08	Photocure Sees Potential in US FDA's Proposed Reclassification of Cystoscopy Systems
14/08	Photocure ASA Initiates FDA Proposal To Reclassify Blue Light Cystoscopy Systems From Class III To Class II
14/08	Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II
11/08	Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.
11/08	Photocure ASA Publishes Healthcare Resource Utilization And Costs Study For Blue Light Versus White Light Cystoscopy In Non?Muscle-Invasive Bladder Cancer
07/08	Photocure ASA: Notification of primary insider transactions
07/08	Photocure ASA - Share option grant to members of the board of directors
04/08	Photocure Faces $6.6 Million Counterclaim in Asieris Arbitration
04/08	Photocure ASA: Asieris counterclaim on milestone payment arbitration
29/07	Photocure ASA - Share option grant
29/07	Photocure ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
29/07	Photocure ASA: Results for the second quarter of 2026
23/07	Photocure : initiates arbitration in partial milestone payment case with Asieris Pharmaceuticals
22/07	Photocure ASA: Invitation to presentation of second quarter 2026 financial results
14/07	Photocure ASA - Share option grant
30/06	Photocure ASA Announces CFO Transition
30/06	Photocure CFO to Retire
30/06	Photocure ASA - CFO transition
26/06	Photocure ASA: Annual general meeting held
09/06	Photocure, Artera Enter Research Partnership for Bladder Cancer Diagnostics
08/06	Photocure ASA and Artera Partner on Digital Pathology AI Test Evaluation for Bladder Cancer
08/06	Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer
05/06	Photocure ASA - Notice of the Annual General Meeting 26 June 2026
04/06	Photocure Buys US-based Vesica Health for $31 Million